Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial.

Ghidini, Michele; Hochster, Howard; Doi, Toshihiko; Van Cutsem, Eric; Makris, Lukas; Takahashi, Osamu; Benhadji, Karim A; Mansoor, Wasat

Ghidini, Michele; Hochster, Howard; Doi, Toshihiko; Van Cutsem, Eric; Makris, Lukas; Takahashi, Osamu; Benhadji, Karim A; Mansoor, Wasat.

Affiliation

Ghidini M; Oncology Division, Azienda Socio Sanitaria Territoriale di Cremona, Azienda Ospedaliera di Cremona, Viale Concordia 1, 26100, Cremona, Italy. micheleghidini@outlook.com.
Hochster H; Gastrointestinal Oncology, Rutgers Cancer Institute, New Brunswick, NJ, USA.
Doi T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Chiba, Japan.
Van Cutsem E; Digestive Oncology, University Hospitals Gasthuisberg, Leuvain, Belgium.
Makris L; Stathmi, Inc, New Hope, PA, USA.
Takahashi O; Taiho Oncology, Inc., Princeton, NJ, USA.
Benhadji KA; Taiho Oncology, Inc., Princeton, NJ, USA.
Mansoor W; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Gastric Cancer ; 26(4): 626-637, 2023 07.

Article in En | MEDLINE | ID: mdl-37106214

Subject(s)
Key words

Body weight loss; Gastric cancer; gastroesophageal junction cancer; Prognostic factor; Trifluridine tipiracil

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Colorectal Neoplasms Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Italia Country of publication: Japón

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google